Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2

Chemical Research in Toxicology

Volumn 11, Issue 8, 1998, Pages 925-936

  Turesky, Robert J ^a   Constable, Anne ^a   Richoz, Janique ^a   Varga, Nathalia ^a   Markovic, Jovanka ^a   Martin, Martha V ^b   Guengerich, F Peter ^b  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE; CYTOCHROME P450; POLYCHLORINATED BIPHENYL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PURIFICATION; LIVER MICROSOME; METABOLIC ACTIVATION; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN EXPRESSION; PROTEIN INTAKE; RAT; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; BIOTRANSFORMATION; CARCINOGENS; CYTOCHROME P-450 CYP1A2; HUMANS; IMIDAZOLES; MALE; MICROSOMES, LIVER; QUINOXALINES; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY;

ANIMALIA; BACTERIA (MICROORGANISMS); RODENTIA;

EID: 0031815379     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980022n     Document Type: Article

References (62)

1. Ames, B. N., Gold, L. S., and Willet, W. C. (1995) The causes and prevention of cancer. Proc. Natl. Acad. Sci. U.S.A. 92, 5258-5265.
2. Ames, B. N., and Gold, L. S. (1997) Envrionmental pollution, pesticides, and the prevention of cancer: misconceptions. FASEB J. 11, 1041-1052.
3. Felton, J. S., and Knize, M. G. (1990) Heterocyclic amine mutagens/carcinogens in foods. In Handbook of Eexperimental Pharmacology Cooper, C. S., and Grover, P. L. (Eds.) pp 471-502, Springer-Verlag, Berlin, Heidelberg.
4. Wakabayashi, K., Nagao, M., Esumi, H., and Sugimura, T. (1992) Food-derived mutagens and carcinogens. Cancer Res. (Suppl.) 52, 2092s-2098s.
5. Sinha, R., Rothman, N., Brown, E. D., Salmon, C. P., Knize, M. G., Swanson, C. S., Rossi, S. C., Mark, S. D., Levander, O. A., and Felton, J. S. (1995) High concentrations of the carcinogen 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method. Cancer Res. 55, 4516-4519.
6. Nagao, M., Wakabayashi, K., Ushijima, T., Toyota, M., Totsuka, Y., and Sugimura, T. (1996) Human exposure to carcinogenic heterocylic amines and their mutational fingerprints in experimental animals. Environ. Health Persp. (Suppl.) 104, 497-501.
7. Adamson, R. H., Thorgeirsson, U. P., Snyderwine, E. G., Reeves, J., Dalgard, D. W., Takayama, S., and Sugimura, T. (1990) Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: induction of tumors in three macaques. Jpn. J. Cancer Res. 81, 10-14.
8. Gaylor, D. W., and Kadlubar, F. F. (1991) Quantitative risk assessments of heterocyclic amines in cooked foods. In Mutagens in Foods: Detection and Prevention (Hayatsu, H., Ed.) pp 229-236, CRC Press, Boca Raton, FL.
9. Stavric, B. (1994) Biological significance of trace levels of mutagenic heterocyclic aromatic amines in human diet: a critical review. Fd, Chem. Toxic. 32, 977-994.
10. Layton, D. W., Bogen, K. T., Knize, M. G., Hatch, F. T., Johnson, V. M., and Felton, J. S. (1995) Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. W Carcinogenesis 16, 39-52.
11. Lutz, W. K., and Schlatter, J. (1992) Chemical carcinogens and overnutrition in diet-related cancer. Carcinogenesis 13, 2211-2216.
12. Hammons, G. J. and Kadlubar, F. F. (1987) The role of cytochrome P-450 in the metabolism of carcinogens. In Mammalian Cytochromes P-450 (Guengerich, F. P., Ed.) pp 81-130, CRC Press, Boca Raton, FL.
13. Guengerich, F. P. (1997) Comparisons of catalytic selectivity of cytochrome P450 subfamily members from different species. Chem.-Biol. Interact. 106, 161-182.
14. Kato, R. (1986) Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. CRC Crit, Rev. Toxicol. 16, 307-348.
15. Yamazoe, Y., Abu-Zeid, M., Manabe, S., Toyama, S., and Kato, R. (1988) Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified cytochrome P-450. Carcinogenesis 9, 105-109.
16. Turesky, R. J., Lang, N. P., Butler, M. A., Teitel, C. H., and Kadlubar, F. F. (1991) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 12, 1839-1845.
17. PA (P450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. U.S.A. 86, 7696-7700.
18. Wrighton, S. A., Campanile, C., Thomas, P. E., Maines, S. L., Watkins, P. B., Parker, G., Mendez-Picon, G., Haniu, M., Shively, J. E., Levin. W., and Guzelian, P. S. (1986) Identification of a human liver cytochrome P-450 homologous to the major isosafroleinducible cytochrome P-450 in the rat. Mol. Pharmacol. 29, 410.
19. Boobis, A. R., Gooderham, N. J, Rich, K. J., Zhao, K., Edwards, R. J., Murray, B. P., Lynch, A. M., Murray, S., and Davies, D. S. (1992) Enzymatic studies of the activation of heterocyclic food mutagens in man. In Proceedings of the 23rd Internation Symposium of the Princess Takamatsu Cancer Research Fundam. Heterocyclime amines in cooked foods: Possible human carcinogens (Adamson, R. H., Gustafsson, J.-A., Ito, N., Nagao, M. Sugimura, T., Wakabayashi, K., and Yamazoe, Eds.) pp 134-144, Princeton Scientific Publishing Co., Princeton, NJ.
20. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56, 2979-2984.
21. Yamazoe, Y., Abu-Zeid, M., Yamauchi, K., and Kato, R. (1988) Metabolic activation of pyrolysate arylamines by human liver microsomes: possible involvement of a P-448-H type cytochrome P-450. Jpn. J. Cancer Res. 79, 1159-1167.
22. Gooderham, N. J., Murray, B. P., Murray, S., Boobis, A. R., and Davies, D. S. (1990) Exposure to, and activation of, the food derived mutagenic heterocyclic amine MeIQx. In Mutation and the Environment. Part B: Metabolism, Testing Methods, and Chromosomes (Mendelsohn, M. L., and Albertini, R. J., Eds.) New York. pp 67-76, Wiley-Liss, Inc.,
23. Davis, C. D., Schut, H. A. J., Adamson, R. H., Thorgeirsson, U. P., Thorgeirsson, S. S., and Snyderwine, E. G. (1994) Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro relects low DNA adduct levels in vivo. Carcinogenesis 14, 61-65.
24. McManus, M. E., Burgess, W. M., Stupans, I., Trainor, K. J., Fenech, M., Robson, R. A., Morley, A. A., and Snyderwine, E. G. (1988) Activation of the food-derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline by human-liver microsomes. Mutation Res. 204, 185-193.
25. Kadlubar, F. F., Butler, M. A., Kaderlik, K. R., Chou, H.-C., and Lang, N. P. (1992) Polymorphisms for aromatic amine metabolism in humans: relevance for human Carcinogenesis. Environ. Health Perspect. 98, 69-74.
26. Turesky, R. J., Bracco-Hammer, I., Markovic, J., Richli, U., Kappeler, A.-M., and Welti, D. H. (1990) The contribution of N-oxidation to the metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat hepatocytes. Chem. Res. Toxicol. 3, 524-535.
27. Turesky, R. J., Markovic, J., Bracco-Hammer, I., and Fay, L. B. (1991) The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino3,8-dimethylimidazo[4,5-f]quinoxaline. Carcinogenesis 12, 1847-1855.
28. Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V., and Kaminsky, L. S. (1982) Purification and characterization of liver rnicrosomal cytochrome P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital orβ-naphthoflavone. Biochemistry 21, 6019-6030.
29. Sandhu, P., Guo, Z., Baba, T., Martin, M. V., Tukey, R. H., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activites of the enzyme. Arch. Biochem. Biophys. 309, 168-177.
30. Yasukochi, Y., and Masters, B. S. S. (1976) Some properties of a detergent-solubilized NADPH-cytochrome c (Cytochrome P-450) reductase purified by biospecific affinity chromatography. J. Biol. Chem. 251, 5337-5344.
31. Guengerich, F. P. (1994) Analysis and characterization of enzymes. In Principles and Methods of Toxicology (Hayes, A. W., Ed.) pp 1259-1313, Raven Press, Ltd., New York.
32. Souček, P., Martin, M. V., Ueng, Y.-F., and Guengerich, F. P. (1995) Identification of a common epitope near the conserved heme-binding region with polyclonal antibodies raised against cytochrome P450 family 2 proteins. Biochemistry 34, 16013-16021.
33. Guengerich, F. P., Wang, P., and Davidson, N. K. (1982) Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry 21, 1698-1706.
34. Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haaparanta, T., and Mayer, R. T. (1985) Ethoxy-, pentoxy- and benzyloyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochome P-450. Biochem. Pharmacol. 34, 3337-3345.
35. Shimada, T., Oda, Y., Yamazaki, H., Mimura, M. and Guengerich, F. P. (1994) SOS function tests for studies of chemical carcinogenesis in Salmonella typhimurium TA 1535/pSK1002, NM2009, and NM3009. In Methods in Molecular Genetics Vol. 5, Gene and Chromosome Analysis (Adolph, K. W., Ed.) pp 342-355, Academic Press, Orlando.
36. Davis, C. D., Adamson, R. H., and Snyderwine, E. G. (1993) Studies on the mutagenic activation of heterocyclic amines by cynomolgus monkey, rat and human microsomes show that cynomolgus monkeys have a low capacity to N-oxidize the quinoxaline-type heterocyclic amines. Cancer Lett. 73, 95-104.
37. Turesky, R. J., Garner, R. C., Welti, D. H., Richoz, J., Leveson, S. H., Dingley, K. H., Turteltaub, K. W., and Fay, L. B. (1998) Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans. Chem. Res, Toxicol. 11, 217-225.
38. Wallin, H., Mikalsen, A., Guengerich, F. P., Ingelman-Sundberg, I., Solberg, K. E., Rossland, O. J., and Alexander, J. (1990) Differential rates of metabolic activation and detoxification of the food mutagen 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymes. Carcinogenesis 11, 489-492.
39. Shimada, T., Yun, C.-H., Yamazaki, H., Gautier, J.-C., Beaune, P. H., and Guengerich, F. P. (1992) Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol. 41, 856-864.
40. Eugster, H.-P., Probst, M., Würgler, F. E., and Sengstag, C. (1993) Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Drug Metab. Disp. 21, 43-49.
41. Guengerich, F. P. (1995) Human cytochrome P450 enzymes. In Cytochrome P450 (Ortiz de Montellano, P. R., Ed.) pp 473-535, Plenum Press, New York.
42. Belloc, C., Baird, S., Cosme, J., Lecoeur, S., Gautier, J.-C., Challine, D., de Waziers, I., Flinois, J.-P., and Beaune, P. H. (1996) Human cytochrome P450 expressed in Escherichia coli: production of specific antibodies. Toxicology 106, 207-219.
43. Guengerich, F. P., and Turvy, C. G. (1991) Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256, 1189-1194.
44. Sesardic, D., Boobis, A. R., Edwards, R. J., and Davies, D. S. (1988) A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 26, 363-372.
45. Kamataki, T., Maeda, K., Yamazoe, Y., Matsuda, N., Ishii, K., and Kato, R. (1983) A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Mol. Pharmacol. 24, 146-155.
46. Namkung, M. J., Yang, H. L., Hulla, J. E., and Juchau, M. R. (1988) On the substrate specificity of cytochrome P450IIIA1. Mol. Pharmacol. 34, 628-637.
47. Hammons, G. J., Milton, D., Stepps, K., Guengerich, F. P., and Kadlubar, F. F. (1997) Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis 18, 851-854.
48. Sesardic, D., Boobis, A. R., Murray, B. P., Murray, S., Segura, J., de la Torre, R., and Davies, D. S. (1990) Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Br. J. Clin. Pharmacol. 29, 651-663.
49. Voorman, R., and Aust, S. D. (1987) Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity. Toxicol. App. Pharmacol. 90, 69-78.
50. Voorman, R., and Aust, S. D. (1988) Inducers of cytochrome P-450d: influence of microsomal catalytic activities and differential regulation by enzyme stabilization. Arch. Biochem. Biophys. 262, 76-84.
51. Pastrakuljic, A., Tang, B. K., Roberts, E. A., and Kalow, W. (1997) Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole. Biochem. Pharmacol. 53, 531-538.
52. Kunze, K. L., and Trager, W. F. (1993) Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furarylline. Chem. Res. Toxicol. 6, 649-656.
53. Boobis, A. R., Sesardic, D., Murray, B. P., Edwards, R. J., Singleton, A. M., Rich, K. J., Murray, S., de la Torre, R., Segura, J., Pelkonen, O., Pasanen, M., Kobayashi, S., Zhi-Guang, T., and Davies, D. S. (1990) Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors. Xenobiotica 20, 1139-1161.
54. Butler, M. A., Guengerich, F. P., and Kadlubar, F. F. (1989) Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′methylenebis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res. 49, 25-31.
55. Raza, H., King, R. S., Squires, R. B., Guengerich, F. P., Miller, D. W., Freeman, J. P., Lang, N. P., and Kadlubar, F. F. (1996) Metabolism of 2-amino-α-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P450 1A2. Drug Metab. Disp. 24, 395-400.
56. Felton, J. S., and Healy, S. K. (1984) Activation of mutagens in cooked ground beef by human liver microsomes. Mutation Res. 140, 61-65
57. Shimada, T., Iwasaki, M., Martin, M. V., and Guengerich, F. P. (1989) Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Cancer Res. 49, 3218-3228.
58. Jaiswal, A. K., Gonzalez, F. J., and Nebert, D. W. (1985) Human dioxin-inducible cytochrome P1-450: complementary DNA and amino acid sequence. Science 228, 80-83.
59. 3-P450: cDNA and complete protein sequence, repetitive Alu sequences in the 3′ nontranslated region and localization of gene to chromosome 15. J. Exp. Pathol. 3, 1-17.
60. 5. Arch. Biochem. Biophys. 348, 107-117.
61. Degawa, M., Tanimura, S., Agatsuma, T., and Hashimoto, Y. (1989) Hepatocarcinogenic heterocyclic aromatic amines that induce cytochrome P-448 isozymes, mainly cytochrome P-448H (P-450IA2), responsible for mutagenic activation of the carcinogens in rat liver. Carcinogenesis 10, 1119-1122.
62. Edwards, R. J., Murray, B. P., Murray, S., Schulz, T., Neubert, D., Gant, T. W., Thorgeirsson, S. S., Boobis, A. R., and Davies, D. S. (1994) Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and humans. Carcinogenesis 15, 829-836.